Heart Failure Reviews

Papers
(The median citation count of Heart Failure Reviews is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome44
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making43
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction35
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis32
Right ventricular failure: a comorbidity or a clinical emergency?31
The cardiosplenic axis: the prognostic role of the spleen in heart failure29
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris27
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction27
The role of TAVR in patients with heart failure: do we have the responses to all questions?26
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?25
Correction to: Is it time to revisit ICD indications?25
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition23
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?23
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers21
Speckle tracking echocardiography in heart failure development and progression in patients with apneas20
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging20
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond19
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease19
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study18
Letter to the editor to update the article “Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials”18
Targeting mitochondrial dysfunction with elamipretide17
Left ventricular assist device in cardiac amyloidosis: friend or foe?15
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review14
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure14
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era14
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202113
Letter to the Editor13
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy12
Experimental heart failure models in small animals12
New onset nonischemic cardiomyopathy post liver transplantation11
Large animal models of heart failure with preserved ejection fraction10
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure9
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature9
Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools9
Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases8
Soluble ST2: a valuable prognostic marker in heart failure7
Immunity and inflammation: the neglected key players in congenital heart disease?6
Pirfenidone as a novel cardiac protective treatment6
Histamine receptors in heart failure6
Evaluation of donor heart for transplantation6
Is it time to revisit ICD indications?6
Heart failure with a preserved ejection fraction and the EMPEROR-Preserved Trial: a review of how we got here6
Discussion of LBBP synchronization effects in HF patients with LBBB and comparison with BiV-CRT6
0.32375001907349